Our understanding of ourselves has greatly expanded since the first genome sequence was released 25 years ago. However, our genome still presents many challenges to comprehending the problems related to human diseases. The Precision Medicine Initiative announced by US President Barack Obama in the State of the Union Address on January 20, 2015 is a bold new research effort aiming to customize healthcare with medical decisions, practices, and/or products tailored to the individual patient. Considering the major goals of precision medicine-to improve human health and treat disease-genetics and genomics can play important roles in identifying the genetic basis of diseases, elucidating the underlying biological mechanisms in the development of diseases, and discovering genetic factors for individual drug responsiveness. From that point of view, Genes & Genomics intended to provide a forum for discussing precision medicine-related topics and invited articles and reviews for a special issue on the theme of ''Translational Genomics for Human Diseases''. The editorial board carefully screened a number of papers submitted to the journal. A total of eight research articles and one review have been selected for the intended special issue. We hope that the special issue provides our readers with an update and overview of the development of concepts, technologies, and applications of the humangenome database to help overcome human diseases and meet the goals of precision medicine.
One of the major surprising findings from the human genome is that the number of coding genes is far less than what we originally thought. It was hardly believable that only about 20,700 genes can account for the human complexity from the view of the early classical dogma of ''onegene-one-protein'', which was oversimplified (Consortium 2012) . We now know that the actual gene-protein relationship is much more complex, often being viewed as ''onegene-many-proteins'' or ''one-gene-many-functions''. The expansion of functions of single genes is provided mainly through alternate splicing (AS). Indeed, AS affects more than 86 % of human genes. Uversky (2016) summarized the effects of aberrations in AS on some key, intrinsically disordered proteins and the pathogenesis of neurodegenerative diseases, cardiovascular disease, cancer, and diabetes. With extensive reviews on the relation between AS and human diseases, he suggests that understanding of the molecular mechanisms underlying the modulation of the biological activities of numerous spliced variants contributes to new drug discovery.
Of the many diabetes mellitus-associated complications, diabetic nephropathy (DN) is the most challenging. DN affects *30 % of patients with long-standing diabetes, and the prevalence of DN is increasing continuously, posing a major challenge to the health-care system in modern society (Ahn et al. 2014) . One research article was included in this special issue on the functional mechanisms of DNassociated genetic variants (Gong et al. 2016 ). Gong and colleagues reported two single-nucleotide polymorphisms (SNPs) (rs3135377 and rs 9469220) that act as cis-effect regulators of the gene identified for DN by conducting integrative analyses (comprising expression analysis of quantitative-trait loci, differential gene-expression analysis, and functional prediction analysis) using a publicly available dataset. The authors also predict that those two SNPs might act as regulatory sites based on online prediction tools. Their findings provide potential mechanistic links underlying the association between DN and the two identified SNPs.
Another research article in this issue is on chronic kidney disease. Lim et al. (2016) reported on a genetic-association study to detect genetic loci for kidney functionrelated traits such as blood urea nitrogen (BUN) and blood albumin levels in subjects stratified by diabetic status. Their genome-wide association analyses detected one locus, LOC105374266, showing a significant association with BUN in nondiabetic normal subjects. That locus might provide new insight into genetic predisposition to chronic kidney disease in human populations. They also extended their association studies between kidney function-related traits and three microRNA variants from which micro-RNA-related SNPs were selected from two population cohorts. Their findings provide a clue of the functional role of microRNA in the development of chronic kidney disease in human populations.
Mesenchymal stem cells (MSCs) and stromal cells derived from MSCs have been recognized as key players in carcinogenesis, affecting tumor growth, development, and progression during the early stages of tumorogenesis. It was known that those cells can influence the construction of the microenvironment, epithelial mesenchymal transit, and metastasis (Calon et al. 2015) . A research article in this issue deals with DNA methylation changes in the genes in the extracellular matrix (ECM) remodelling pathway during the transformation of human MSCs (Kim et al. 2016a ). The ECM provides physical support for tissue specificity and elasticity in the form of basement membrane. It is also a dynamic structure that is constantly remodeled to control tissue homeostasis. The authors found that promoter hypermethylation was correlated with transcription silencing in three ECM genes (LAMA1, FBN2, and IGFBP3) during the transformation of an MSC model system in human colon cancer-cell lines. Their findings suggest that epigenetic alterations in ECM-pathway genes might contribute to carcinogenesis.
Spinal cord injury (SCI) is a devastating neurological disorder. Because it accompanies long-lasting disability and limited response to acute drug administration and efforts at rehabilitation, it impacts enormously on the quality of life and economy of patients. It is commonly estimated that more than 2.5 million people suffer from SCI, and more than 130,000 new cases are reported worldwide each year (McDonald and Sadowsky 2002) . In this issue, Peng et al. (2016) analyzed the potential pathways and target genes in SCI using bioinformatic approaches. They reported 173 overlapping, differentially expressed genes (DEGs) between raphe-magnus and sensorimotor-cortex samples by analyzing publicly available microarray data. Findings from their pathway-enrichment analysis indicate that overlapping DEGs in SCI are mainly related to inflammation and immunity. They identified several key genes (RAC2, CD44, and APRC1B) that impact on the pathogenesis of SCI by participating in different pathways. The bioinformatic approaches revealed potential pathways and target genes in SCI, however, the results obtained from their bioinformatic methods need further experimental studies to verify the findings.
Alzheimer's disease (AD) is a neurodegenerative disease accounting for 60-70 % of cases of dementia (Burns and Lliffe 2009) . It usually starts slowly and gets worse over time until cognitive abilities are completely lost. Using AD model mice, Lee and Choe (2016) reported region-specific changes in the distribution of transient receptor potential vanilloid 4 channel (TRPV4) in the central nervous system. They found that TRPV4 was upregulated in the cerebral cortex, hippocampal formation, striatum, and thalamus of early-stage and late-stage AD model mice compared with that in control mice. They also found increased expression of TRPV4 in the hippocampal formation, striatum, and thalamus of late-stage AD model mice, which was the first demonstration of AD-related increases in TRPV4 expression in the brain. Their findings provide a useful clue to understanding the development of AD-related neurodegenerative diseases. Understanding the functional significance of the regulation of TRPV4 in AD will require further research.
Edwards' syndrome (ES) is also known as trisomy 18. Its frequency is about 1 in 6000 individuals, of which 80 % are female (http://www.trisomy18.org/what-is-trisomy-18/). ES fetuses are prone to miscarrige, with an abortion rate of 72-87 % (Lakovschek et al. 2011) . When abortion does not occur, babies are highly underdeveloped and die within 1 year of birth (Sibiude et al. 2011 present an article in this issue on the use of three short tandem repeat (STR) loci (D18S53, D18S59, and D18S488) in the diagnosis of ES. For that purpose, they used quantitative fluorescence PCR. The technique was highly sensitive, specific, simple, and rapid. Their report suggests clinical applications of the three STRs to the large-scale genetic and prenatal diagnosis of ES.
Defensins are cystein-rich cationic proteins 19-45 amino acids in length found in both vertebrates and invertebrates as well as in plants. They are active agents against pathogenic bacteria, fungi, and some viruses (Lehrer 2004) . Human beta-defensins play a crucial role in innate immune responses, acting at the initial stages of immune defense against microbial infections. An article in this issue reports on genetic associations between DEFB1 polymorphisms and chronic respiratory diseases (CRDs) based on a meta-analysis comprising 1343 CRD cases and 1261 healthy controls (Ran et al. 2016) . Two SNPs showed strong evidence of association with CRD susceptibility. Those findings imply the functional relevance of DEFB1 to the development of CRDs.
Charcot-Marie-Tooth (CMT) disease is a genetically and clinically heterogeneous disorder that is associated with more than 80 causative genes (Rossor et al. 2013) . Kim et al. (2016b) report in this issue on the genotypephenotype correlation of CMT type 1E patients with peripheral myelin protein 22 (PMP22) mutations. For their analysis, they performed whole-exome sequencing, histological examination of the distal sural nerves, and magnetic resonance imaging of the legs of two patients. They found two de novo mutations in PMP22 in both patients. They found that two missense mutations are correlated with the patients' numerous characteristic phenotypes. Their findings provide a clue to understanding the genetic causes of CMT and a way to approach CMT diagnosis.
